Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities
Net income	$ 246,112	$ 193,327
Adjustments to net income:
Depreciation and amortization	227,641	195,725
Amortization of deferred financing costs and other noncash interest expense	7,357	7,396
Amortization of equity-based compensation	9,249	24,161
Provisions for impairment	12,962	17,350
Net gain on dispositions of real estate	(17,013)	(32,271)
Loss (income) from non-real estate, equity method investments	2,347	(804)
Distributions received from non-real estate, equity method investment	468
Noncash revenue and other	(4,305)	(6,931)
Changes in operating assets and liabilities:
Other assets	9,344	15,821
Accrued expenses, deferred revenue and other liabilities	7,284	1,004
Net cash provided by operating activities	501,446	414,778
Investing activities
Acquisition of and additions to real estate	(1,097,538)	(953,453)
Investment in loans and financing receivables	(78,834)	(70,744)
Collections of principal on loans and financing receivables	54,616	13,903
Proceeds from dispositions of real estate	177,494	270,897
Contributions made to non-real estate, equity method investment	(468)
Net cash used in investing activities	(944,730)	(739,397)
Financing activities
Borrowings under credit facility	724,000	416,000
Repayments under credit facility	(631,000)	(307,000)
Borrowings under unsecured notes and term loans payable	600,000
Repayments under unsecured notes and term loans payable		100,000
Borrowings under non-recourse debt obligations of consolidated special purpose entities		514,785
Repayments under non-recourse debt obligations of consolidated special purpose entities	(186,791)	(207,823)
Financing costs paid	(3,024)	(10,872)
Proceeds from the issuance of common stock	252,873	191,595
Stock issuance costs paid	(3,296)	(3,272)
Shares repurchased under stock compensation plans	(6,271)	(9,345)
Dividends paid	(323,166)	(293,182)
Net cash provided by financing activities	423,325	190,886
Net decrease in cash, cash equivalents and restricted cash	(19,959)	(133,733)
Cash, cash equivalents and restricted cash, beginning of period	70,049	176,576
Cash, cash equivalents and restricted cash, end of period	50,090	42,843
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	46,979	37,018
Restricted cash included in other assets	3,111	5,825
Total cash, cash equivalents and restricted cash	50,090	42,843
Supplemental disclosure of noncash investing and financing activities:
Accrued tenant improvements included in real estate investments	22,773	18,428
Acquisition of real estate assets from borrowers under loans and financing receivables	8,945	42,782
Accrued financing and stock issuance costs	66	101
Supplemental disclosure of cash flow information:
Cash paid during the period for interest, net of amounts capitalized	127,903	120,575
Cash paid during the period for income and franchise taxes	$ 2,572	$ 2,134